搜索临床试验以:Aes-103
总计1433个结果
-
Baxalta now part of Shire终止
-
Baxalta now part of ShireNational Heart, Lung, and Blood Institute (NHLBI); SAIC-Frederick, Inc.; Cato Research; Therapeutics... 和其他合作者完全的
-
The University of Texas Health Science Center,...U.S. Administration for Community Living完全的
-
Fondazione TelethonOspedale San Raffaele主动,不招人
-
Cellestia Biotech AG终止乳腺癌 | 腺样囊性癌 | 肝细胞癌 | 大肠癌 | 骨肉瘤 | 非霍奇金淋巴瘤 | 血管球瘤,恶性 | 高的美国, 西班牙, 大韩民国, 德国, 法国, 瑞士
-
Homology Medicines, Inc终止
-
Sanofi Pasteur, a Sanofi Company完全的
-
Alexion Pharmaceuticals终止粘多糖贮积症 III,B 型 (MPS IIIB) | 圣菲利波B英国
-
Michael RippeeUniversity of Kansas Medical Center; University of Kansas Health System完全的
-
Gemini Therapeutics, Inc.终止
-
Tenax Therapeutics, Inc.Northwestern University; Medpace, Inc.招聘中
-
Fondazione TelethonOspedale San Raffaele完全的
-
Gemini Therapeutics, Inc.完全的
-
Schiffler Cancer CenterUniversity of Washington; Theragenics完全的
-
Transwell Biotech Co., Ltd.A2 Healthcare Taiwan Corporation完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityEli Lilly and Company尚未招聘The Incidence of AEs and SAEs Receiving Verzenios® Over a Period of Approximately 24 Weeks
-
University Health Network, Toronto完全的
-
Alexion Pharmaceuticals完全的